Skip to main content
Top
Published in: AIDS Research and Therapy 1/2011

Open Access 01-12-2011 | Case report

Possible transmission of HIV Infection due to human bite

Authors: Alaka K Deshpande, Shivaji K Jadhav, Atmaram H Bandivdekar

Published in: AIDS Research and Therapy | Issue 1/2011

Login to get access

Abstract

The potential risk of HIV-1 infection following human bite although epidemiologically insignificant, but it is biologically possible. There are anecdotal reports of HIV transmission by human bites particularly if saliva is mixed with blood. The oral tissues support HIV replication and may serve as a previously unrecognized HIV reservoir. The HIV infected individuals have more viruses in blood than saliva, possibly due to the potent HIV-inhibitory properties of saliva. The case presented here is of a primary HIV infections following a human bite where in the saliva was not blood stained but it got smeared on a raw nail bed of a recipient. The blood and saliva of the source and blood of the recipient showed a detectable viral load with 91% sequence homology of C2-V3 region of HIV gp120 between the two individuals. The recipient did not receive PEP [post exposure prophylaxis] as his family physician was unaware of salivary transmission. The family physician should have taken PEP decision after proper evaluation of the severe and bleeding bite. Hence it is necessary to treat the HIV infected human bites with post exposure prophylaxis.
Appendix
Available only for authorised users
Literature
1.
go back to reference Tereskerz TM, Bentley M, Jagger J: Risk of HIV-1 infection after human bites. Lancet. 1996, 348: 1512-10.1016/S0140-6736(05)65921-1.CrossRefPubMed Tereskerz TM, Bentley M, Jagger J: Risk of HIV-1 infection after human bites. Lancet. 1996, 348: 1512-10.1016/S0140-6736(05)65921-1.CrossRefPubMed
2.
go back to reference Richman KM, Richman LS: The potential for transmission of human immunodeficiency virus through human bites. J Acquir Immune Defic Syndr. 1993, 64: 40-46. Richman KM, Richman LS: The potential for transmission of human immunodeficiency virus through human bites. J Acquir Immune Defic Syndr. 1993, 64: 40-46.
3.
go back to reference Chenine AL, Regina FF, Lehmann H, Vangel MG, McClure HM, Ruprecht RM: Older Rhesus Macaque Infants Are More Susceptible to Oral Infection with Simian-Human Immunodeficiency Virus 89.6P than Neonates Virol. 2005, 2: 1333-1336. Chenine AL, Regina FF, Lehmann H, Vangel MG, McClure HM, Ruprecht RM: Older Rhesus Macaque Infants Are More Susceptible to Oral Infection with Simian-Human Immunodeficiency Virus 89.6P than Neonates Virol. 2005, 2: 1333-1336.
4.
go back to reference Bartholomew CF, Jones AM: Human bites: a rare risk factor for HIV transmission. AIDS. 2006, 4: 631-632. 10.1097/01.aids.0000210621.13825.75.CrossRef Bartholomew CF, Jones AM: Human bites: a rare risk factor for HIV transmission. AIDS. 2006, 4: 631-632. 10.1097/01.aids.0000210621.13825.75.CrossRef
5.
go back to reference Shugars DC, Patton LL, Freel SA, Gray LR, Vollmer RT, Eron JJ, Fiscus SA: Hyper-excretion of human immunodeficiency virus type 1RNA in saliva. J Dent Res. 2001, 2: 414-420.CrossRef Shugars DC, Patton LL, Freel SA, Gray LR, Vollmer RT, Eron JJ, Fiscus SA: Hyper-excretion of human immunodeficiency virus type 1RNA in saliva. J Dent Res. 2001, 2: 414-420.CrossRef
6.
go back to reference Delwart EL, Sheppard HW, Walker BD, Goudsmit J, Mullins JI: HIV-1 evolution in vivo tracked by DNA heteroduplex mobility assays. J Virology. 1994, 68: 6672-6683.PubMedCentralPubMed Delwart EL, Sheppard HW, Walker BD, Goudsmit J, Mullins JI: HIV-1 evolution in vivo tracked by DNA heteroduplex mobility assays. J Virology. 1994, 68: 6672-6683.PubMedCentralPubMed
7.
go back to reference Shirly LR, Ross SA: Risk of transmission of human immunodeficiency virus by bite of an infected toddler. J Pediatrics. 1989, 3: 424-427. Shirly LR, Ross SA: Risk of transmission of human immunodeficiency virus by bite of an infected toddler. J Pediatrics. 1989, 3: 424-427.
8.
go back to reference Andreo SM, Barra LA, Costa LJ, Sucupira MC, Souza E, Diaz RC: HIV type 1 transmission by human bite retroviruses. AIDS Res Hum Retroviruses. 2004, 20: 349-350. 10.1089/088922204323048087CrossRefPubMed Andreo SM, Barra LA, Costa LJ, Sucupira MC, Souza E, Diaz RC: HIV type 1 transmission by human bite retroviruses. AIDS Res Hum Retroviruses. 2004, 20: 349-350. 10.1089/088922204323048087CrossRefPubMed
9.
go back to reference Balamane M, Winters MA, Dalai SC, Freeman AH, Traves MW, Israelski DM, Katzenstein DA, Klausner JD: Detection of HIV-1 in saliva: Implications for case-Identification, clinical monitoring and surveillance for drug resistance. The open Virology Journal. 2010, 4: 78-83. 10.2174/1874357901004010088.CrossRef Balamane M, Winters MA, Dalai SC, Freeman AH, Traves MW, Israelski DM, Katzenstein DA, Klausner JD: Detection of HIV-1 in saliva: Implications for case-Identification, clinical monitoring and surveillance for drug resistance. The open Virology Journal. 2010, 4: 78-83. 10.2174/1874357901004010088.CrossRef
Metadata
Title
Possible transmission of HIV Infection due to human bite
Authors
Alaka K Deshpande
Shivaji K Jadhav
Atmaram H Bandivdekar
Publication date
01-12-2011
Publisher
BioMed Central
Published in
AIDS Research and Therapy / Issue 1/2011
Electronic ISSN: 1742-6405
DOI
https://doi.org/10.1186/1742-6405-8-16

Other articles of this Issue 1/2011

AIDS Research and Therapy 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.